Amedisys Stock Investor Sentiment
| AMED Stock | USD 92.08 0.35 0.38% |
About 68% of Amedisys' investor base is looking to short. The analysis of overall sentiment of trading Amedisys stock suggests that many investors are alarmed at this time. Amedisys' investor sentiment overview provides quick insight into current market opportunities from investing in Amedisys. The current market sentiment, together with Amedisys' historical and current headlines, can help investors time the market. In addition, many technical investors use Amedisys stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
32
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Amedisys' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Amedisys.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Amedisys stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Amedisys daily returns and investor perception about the current price of Amedisys as well as its diversification or hedging effects on your existing portfolios.
Amedisys Historical Sentiment
Although Amedisys' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Amedisys, such as negative comments on social media and news outlets, may cause fear in the market and push Amedisys' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Amedisys.
Amedisys |
Amedisys Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Amedisys can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Amedisys Maximum Pain Price across 2024-05-17 Option Contracts
Amedisys' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Amedisys close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Amedisys' options.
Far too much social signal, news, headlines, and media speculation about Amedisys that are available to investors today. That information is available publicly through Amedisys media outlets and privately through word of mouth or via Amedisys internal channels. However, regardless of the origin, that massive amount of Amedisys data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amedisys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amedisys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amedisys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amedisys alpha.
Amedisys Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Amedisys introduces advanced molecular testing nationwide | 02/09/2024 |
2 | Acquisition by Denise Bohnert of 5518 shares of Amedisys subject to Rule 16b-3 | 02/16/2024 |
3 | Disposition of 1415 shares by Denise Bohnert of Amedisys at 93.69 subject to Rule 16b-3 | 02/20/2024 |
4 | Amedisys, Inc. Position Lifted by Vanguard Group Inc. - Defense World | 03/28/2024 |
5 | DOJ case against UnitedHealth could take years to resolve, says BoA | 04/19/2024 |
6 | Heres Why Amedisys is a Strong Value Stock | 04/23/2024 |
7 | Amedisys Non-GAAP EPS of 1.03 beats by 0.02, revenue of 571.41M beats by 2.16M | 04/24/2024 |
8 | Compared to Estimates, Amedisys Q1 Earnings A Look at Key Metrics | 04/25/2024 |
9 | Handelsbanken Fonder AB Reduces Stock Holdings in Amedisys, Inc. - MarketBeat | 05/01/2024 |
Check out Amedisys Hype Analysis, Amedisys Correlation and Amedisys Performance. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share (0.64) | Revenue Per Share 69.004 | Quarterly Revenue Growth 0.027 | Return On Assets 0.0626 |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.